Template:PDB Gallery/1520

• 
  1glo: CRYSTAL STRUCTURE OF CYS25SER MUTANT OF HUMAN CATHEPSIN S
• 
  1ms6: Dipeptide Nitrile Inhibitor Bound to Cathepsin S.
• 
  1npz: Crystal structures of Cathepsin S inhibitor complexes
• 
  1nqc: Crystal structures of Cathepsin S inhibitor complexes
• 
  2c0y: THE CRYSTAL STRUCTURE OF A CYS25ALA MUTANT OF HUMAN PROCATHEPSIN S
• 
  2f1g: Cathepsin S in complex with non-covalent 2-(Benzoxazol-2-ylamino)-acetamide
• 
  2fq9: Cathepsin S with nitrile inhibitor
• 
  2fra: Human Cathepsin S with CRA-27934, a Nitrile Inhibitor
• 
  2frq: Human Cathepsin S with Inhibitor CRA-26871
• 
  2ft2: Human Cathepsin S with Inhibitor CRA-29728
• 
  2fud: Human Cathepsin S with Inhibitor CRA-27566
• 
  2fye: Mutant Human Cathepsin S with irreversible inhibitor CRA-14013
• 
  2g6d: Human cathepsin S mutant with vinyl sulfone inhibitor CRA-14009
• 
  2g7y: Human Cathepsin S with inhibitor CRA-16981
• 
  2h7j: Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor.
• 
  2hh5: Crystal Structure of Cathepsin S in complex with a Zinc mediated non-covalent arylaminoethyl amide
• 
  2hhn: Cathepsin S in complex with non covalent arylaminoethyl amide.
• 
  2hxz: Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor (Hexagonal spacegroup)
• 
  2op3: The structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substrate Activity Screening (SAS) method